Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
GLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing Plaintiffs’ experts have maintained that there are multiple reliable ways to diagnose gastroparesis, which should not require specific testing results that doctors often do not order when the injury first surfaces. March 17, 2025 Irvin Jackson Add Your Comments Eli Lilly, the manufacturer of the diabetes drug Mounjaro and the weight loss drug Zepbound, is asking the U.S. District Judge presiding over all GLP-1 stomach paralysis lawsuits to put stringent requirements in place for establishing that plaintiffs have a gastroparesis diagnosis after using the medications. Mounjaro and Zepbound are part of the same new class of drugs as blockbuster treatments Ozempic and Wegovy, known as glucagon-like peptide-1 (GLP-1) receptor agonists, which are widely used for the treatment of type 2 diabetes and for weight loss. Amid growing popularity of the drugs in recent years, both Eli Lilly and other GLP-1 manufacturers now face more than 1,500 Ozempic lawsuits, Wegovy lawsuits, Mounjaro lawsuits and other claims brought by former users of the medications, who indicate that they developed a severe form of stomach paralysis, known as gastroparesis. Each of the lawsuits raises similar allegations, indicating that the drug makers knew or should have known about the potential gastroparesis side effects, but placed a desire for profits above consumer safety, by withholding critical warnings and safety information from consumers and the medical community. Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Given common questions of fact and law raised in complaints brought throughout the federal court system, all GLP-1 lawsuits have been centralized as part of a multidistrict litigation (MDL) in the Eastern District of Pennsylvania, where they are currently being overseen by U.S. District Judge Karen Marston. To effectively manage the rapidly growing litigation, Judge Marston established a pretrial process that directed the parties to focus early discovery and motions practice on resolving a number of “cross-cutting” issues in the GLP-1 lawsuits, including whether plaintiffs should be required to present specific diagnostic testing evidence to substantiate their injuries, whether the claims are preempted by federal law, and whether there is sufficient general causation evidence linking gastrointestinal injuries to GLP-1 drugs, which is expected to address whether the failure to warn claims survive. In a motion (PDF) filed on March 5, Eli Lilly called for Judge Marston to issue an order requiring contemporaneous objective testing as the only means by which a gastroparesis injury can be diagnosed. Although plaintiffs’ experts have maintained that there is more than one reliable way to diagnose the condition, Eli Lilly wants the judge to exclude those opinions from being presented at trial. “The overwhelming majority—more than 80 percent—of Plaintiffs in this MDL allege gastroparesis as an injury. One of the defining features of gastroparesis is delayed gastric emptying, accompanied by gastrointestinal symptoms like early fullness after meals, abdominal pain, nausea, vomiting, belching, and bloating,” the motion states. “These symptoms are non-specific; they overlap with many other, more common conditions; and they do not alone reliably indicate delayed gastric emptying or gastroparesis.” The manufacturer claims that gastroparesis is misdiagnosed as much as 80% of the time without objective testing. Plaintiffs have not yet responded to the motion, and it is unclear how many claims would be affected by the motion, if Judge Marston approves it. March 2025 GLP-1 Lawsuits Update The lawyers involved in the litigation are scheduled to meet with Judge Marston for a status conference tomorrow, on March 18. According to an agenda (PDF) submitted by the parties last week, the pending motion to require contemporaneous diagnostic testing in gastroparesis lawsuits is not expected to be addressed by the court at the conference. However, the parties have asked Judge Marston to review deposition protocols, a coordination order and a short form complaint that future plaintiffs can use to file their lawsuits. After the “cross-cutting” issues are resolved, and if the lawsuits are cleared to move forward, Judge Marston is expected to schedule a series of early bellwether trials, which will test how juries may respond to certain evidence and testimony likely to be repeated throughout the litigation. Due to the time needed to resolve the “cross-cutting” issues and then select and prepare a group of early cases for trial, the first GLP-1 lawsuits are unlikely to go before federal juries until at least 2027. While the outcomes of these early test cases will not be binding on other claims, they will be closely watched and may help the parties negotiate GLP-1 settlements to resolve large numbers of lawsuits in the future. Find Out If You Qualify for Ozempic or Wegovy Compensation Tags: Diabetes, Diabetes Drugs, Eli Lilly, Gastroparesis, Mounjaro, Novo Nordisk, Ozempic, Stomach Paralysis, Weight Loss Image Credit: Shutterstock: MKPhoto12 Written By: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. More Ozempic, Wegovy and Mounjaro Stories Ozempic, Wegovy Kidney Side Effects Highlighted in New Study October 10, 2025 Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue October 7, 2025 Reports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s October 3, 2025 1 Comments Anna Marie March 19, 2025 I feel that this drug is causing a lot of these issues as all my tests came back as GP and the only change was the Ozempic when all the symptoms came on EmailThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (Posted: yesterday) Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (10/08/2025)Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025) MDL Sought for Lyft Lawsuits Over Sexual Assaults by Drivers (Posted: 2 days ago) A group of plaintiffs are asking a panel of federal judges to consolidate all Lyft lawsuits involving driver sexual assaults against passengers before one judge as part of a Lyft MDL. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITJury Finds Uber Failed To Protect Passengers, But Is Not Liable for Sexual Assault (10/01/2025)Lyft Sexual Assault Lawsuit Alleges Problems With Predatory Drivers Were Known for Years (09/25/2025)Two Uber Sexual Assault Bellwether Trials To Be Held in North Carolina (09/22/2025) Breast Mesh Problems Prompted FDA Warnings Over Off-Label Use (Posted: 3 days ago) Federal regulators warned years ago that mesh implants were never approved for use in breast surgery, yet manufacturers continued marketing them as internal bra devices for reconstruction and cosmetic augmentation. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)
Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue October 7, 2025
Reports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s October 3, 2025
Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (Posted: yesterday) Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (10/08/2025)Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)
MDL Sought for Lyft Lawsuits Over Sexual Assaults by Drivers (Posted: 2 days ago) A group of plaintiffs are asking a panel of federal judges to consolidate all Lyft lawsuits involving driver sexual assaults against passengers before one judge as part of a Lyft MDL. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITJury Finds Uber Failed To Protect Passengers, But Is Not Liable for Sexual Assault (10/01/2025)Lyft Sexual Assault Lawsuit Alleges Problems With Predatory Drivers Were Known for Years (09/25/2025)Two Uber Sexual Assault Bellwether Trials To Be Held in North Carolina (09/22/2025)
Breast Mesh Problems Prompted FDA Warnings Over Off-Label Use (Posted: 3 days ago) Federal regulators warned years ago that mesh implants were never approved for use in breast surgery, yet manufacturers continued marketing them as internal bra devices for reconstruction and cosmetic augmentation. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)